StockData
Sionna Therapeutics, Inc. logo

Sionna Therapeutics, Inc. (SION) stock

SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$3.07−0.05 (-1.60%)

Close on Nov 17, 2026Market cap $138.80MP/E –Yield –

Earnings

Sionna Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 1, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.72
-$0.46 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Sionna Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 1, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026before the open––-$0.72Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open––-$0.66Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open––-$0.60Release
Q4 FY2025ended Dec 31, 2025Mar 2, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open––-$0.46Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025May 12, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025before the open––-$3.38Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Sionna Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Sionna Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Sionna Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?